Worldwide, medical devices are subject to strict regulations, and for good reason, they are crucial for helping health care professionals identify, treat and combat diseases. Strict rules ensure patient safety and treatment efficacy. However, medical device compliance is notoriously tricky.
Regulatory information management systems give business more insight and control over complex laws and standards. These solutions can streamline regulatory compliance, helping your business enjoy faster approval processes and higher overall growth.
Challenges of Medical Device Regulations
Let’s explore some typical obstacles associated with meeting applicable standards and device regulations.
Rapidly Changing Medical Device Regulations
Many medical technology companies struggle to adapt to the constantly evolving regulations. Staying current with the latest standards and maintaining the resources to make changes quickly is particularly challenging for global companies. In 2025 and early 2026 alone, manufacturers have had to absorb the FDA’s QMSR transition, new cybersecurity guidance, and mandatory EUDAMED deadlines, often simultaneously.
Medical Device Regulation Complexity
Navigating the regulatory landscape for medical devices means operating across a patchwork of country and region-specific requirements, each with its own definitions, timelines, and documentation standards. These rules are precise by design since patient safety and device performance depend on it, but the absence of global standardization creates a genuine operational burden for manufacturers trying to stay compliant across multiple markets simultaneously.
The EU is a clear example of how quickly that burden can intensify. Beginning May 28, 2026, EUDAMED, the EU’s centralized medical device database, transitions to mandatory use for all manufacturers placing devices on the EU market. Four key modules have been confirmed as fully functional, meaning manufacturers must now register devices in EUDAMED, including UDI details and economic operator information, before products can be marketed in Europe. For companies that have not yet built EUDAMED readiness into their regulatory workflows, that deadline is approaching fast.
At the same time, the European Commission published a proposal in December 2025 to simplify EU MDR and IVDR, targeting certification bottlenecks, supporting digitalization of regulatory procedures, and introducing more standardized timelines for conformity assessments. It is worth noting that the proposal still needs to clear the European Parliament and Council before it becomes law, and meaningful changes are unlikely before the end of 2026 at the earliest. Manufacturers should track its progress but plan their current compliance programs around the rules as they stand today.
Global Market Access for Medical Devices
Expanding into new markets remains one of the most complex challenges facing medical device manufacturers. Each major market operates under its own regulatory authority from the FDA in the United States, the European Commission and notified bodies under EU MDR, Health Canada, Japan’s PMDA, and dozens of others, each with distinct submission requirements, timelines, and post-market obligations. Meeting one authority’s standards does not automatically satisfy another’s, and managing that complexity across a growing product portfolio adds significant time and cost to market entry.
Supply chain management has added another layer of regulatory risk, particularly in the EU. Under Article 10a of EU Regulation 2024/1860, effective January 2025, manufacturers must proactively notify competent authorities, economic operators, and health institutions of any supply interruption or discontinuation that could result in serious patient harm. With EUDAMED transitioning to mandatory use in May 2026, the stakes are higher still — a device registered as active in the database that becomes unavailable without the required notification exposes manufacturers to double liability under EU law. Supply chain visibility is now a compliance requirement, not just an operational one.
Cybersecurity Concerns
Cybersecurity is now embedded directly into quality systems, design controls, and the market authorization process itself. Regulators have moved decisively in this area, and the obligations manufacturers face today are meaningfully different from those of even two years ago.
In June 2025, the FDA released final guidance on cybersecurity in medical device premarket submissions, establishing that any device containing software, or that is itself software, qualifies as a cyber device under Section 524B of the FD&C Act. This removed previous uncertainty about whether network connectivity was required to trigger cybersecurity obligations. If a device runs software, cybersecurity requirements apply.
The shift from the 2023 guidance is significant. Where earlier guidance treated cybersecurity recommendations as advisory, the 2025 framework is enforceable. Cybersecurity deficiencies can now independently result in denial of market authorization, meaning a technically sound device can be blocked from market entry solely on cybersecurity grounds.
Practical requirements now include submitting a cybersecurity management plan as part of premarket submissions, maintaining a Software Bill of Materials to support ongoing vulnerability monitoring, and establishing documented processes for identifying and addressing security vulnerabilities throughout the device lifecycle. In February 2026, the FDA further updated its cybersecurity guidance to align with the QMSR, reinforcing that security must be designed into devices from the outset rather than addressed after the fact.
For manufacturers, this means cybersecurity can no longer be delegated to IT or treated as a post-market concern. It belongs in design reviews, risk management files, quality system documentation, and post-market surveillance programs, from day one.
RIMS Software for Medical Technology
A regulatory information management system is software designed to centralize and streamline how medical device companies manage compliance data, track regulatory changes, and prepare submissions across global markets. For most organizations, the alternative is a patchwork of spreadsheets, disconnected tools, and manual processes that slow teams down and introduce errors at every stage of the submission process.
Consider the following five factors when selecting RIMS software for your medical device business.
1.Built for Medical Devices
Many RIMS platforms were designed for pharmaceuticals and adapted for medical devices which means the workflows and compliance logic were never built with your industry in mind. Prioritize a platform purpose-built for medical device and medtech companies, where device classification, submission pathways, and registration requirements are built into the foundation, not bolted on.
2. User-Friendly Interface
Prioritize user-friendliness when choosing a RIMS. Your team needs a simple, frustration-free way to handle regulatory compliance standards and documentation. A system with a minimal learning curve will help your medical device company maintain accuracy, productivity and efficiency.
3. AI and Advanced Technology
When picking a RIMS platform, look for AI capabilities that streamline repetitive tasks like document classification, data extraction, and submission preparation. AI powered systems and predictive analytics can also help your team anticipate regulatory changes and identify compliance risks before they become problems.
4. Built-In Regulatory Intelligence
Look for a platform that monitors regulatory changes across global markets for you and surfaces relevant updates directly within your workflows. Most RIMS vendors do not offer this. It requires dedicated infrastructure and continuous monitoring across every market you operate in. The most advanced software can share notifications and alerts with your business as compliance standards change, enabling your team to stay abreast of all relevant regulatory needs.
5. Integration With External Systems
Consider how the platform integrates with your existing systems. Strong integration capability enables fewer data silos, improved consistency across platforms, and more efficient data exchanges keeping submission workflows moving without unnecessary manual handoffs.
The regulatory landscape for medical devices is more complex and fast-moving than ever. Between mandatory EUDAMED deadlines, the shift from QSR to QMSR, enforceable cybersecurity requirements, and supply chain liability obligations in the EU, regulatory teams are being asked to manage more, across more markets, with higher stakes, than at any time before. Keeping pace manually is not realistic for most organizations.
How RegDesk Regulatory Information Management System Supports Medical Device Compliance
RegDesk’s RIMS was built specifically for the medical device industry. That distinction matters because the medical device product lifecycle has its own classification system, its own submission pathways, and its own regulatory authorities, and a purpose-built platform reflects those realities in every workflow.
Centralized Regulatory Data for Medical Devices
RegDesk brings all regulatory information into one place from requirements, to submission documents, compliance records, and market-specific documentation which eliminates the data silos that form when regulatory, quality, and product teams are each working from different systems. For companies managing registrations across multiple markets, a single source of truth is not a convenience, it is a prerequisite for staying in control. As Elaine F. at Thermo Fisher Scientific put it: “This tool consolidates process and document management practically, intuitively and uncomplicatedly.”
Real-Time Regulatory Intelligence
Keeping pace with regulatory changes across 120+ markets manually is not realistic for most regulatory teams. RegDesk monitors those markets continuously and surfaces relevant updates directly within the platform, so teams are working from current requirements rather than discovering changes after a submission has already been prepared. With mandatory EUDAMED deadlines, QMSR implementation, and evolving cybersecurity requirements all hitting simultaneously in 2025 and 2026, that real-time intelligence function is doing more work than ever.
Submission Efficiency and Automation
Regulatory teams spend large amounts of time preparing a single product submission for just one country. RegDesk reduces that burden through workflow automation by handling document management, submissions, tracking, reporting, and more. This lessens the manual effort that can create bottlenecks, delays, and errors. Faster, more accurate submissions mean faster time to market, and fewer back-and-forth cycles with regulatory authorities.
Risk Management and Change Assessment
RegDesk’s change assessment capability allows manufacturers to evaluate how a regulatory update affects their existing registrations before it becomes a compliance problem. Identifying the impact of a change early, whether it is a new guidance document, a revised standard, or a market-specific requirement, gives regulatory teams time to respond proactively rather than reactively. In an environment where a missed update can stall a product in a key market, that early warning function directly protects revenue.
Audit Trails and Inspection Readiness
RIMS platforms like RegDesk track every action creating a detailed and accurate audit trail that supports inspections and regulatory reviews. When an authority asks how a compliance decision was made, or wants to verify the history of a submission, that documentation is available immediately and is organized, traceable, and defensible. For companies facing increasingly rigorous inspection environments across both FDA and EU regulatory frameworks, inspection readiness is not something to build when an audit is announced. It needs to be a continuous state, and RegDesk’s documentation infrastructure supports exactly that.
RegDesk’s Intelligent RIM gives medical device companies the centralized data, real-time regulatory intelligence, and automated workflows needed to stay compliant, move faster, and stay inspection-ready for every device across every market.
We’ll help your business stay ahead of the curve and thrive, despite the many challenges of getting compliant medical devices into the hands of health care professionals worldwide.
Request a Demo of the Regulatory Intelligence Software from RegDesk
Streamline medical device compliance with RegDesk’s holistic RIMS software. Our one-of-a-kind platform features AI-powered automation and real-time regulatory requirements for over 120 markets worldwide.
RegDesk continuously monitors legislation, standards and guidance documents to provide daily alerts regarding evolving medical device regulations. Our software makes life cycle management easier than ever with a single, centralized platform. The distributor collaboration tool and AI-enabled submission generator enable effortless global submission preparation for your operation.
Are you interested in learning more? Request a demo of our cutting-edge solution today.
